Final trial results continue to show benefit from remdesivir for COVID-19

摘要

Final results from a randomized clinical trial continued to show that remdesivir shortens recovery time in hospitalized patients with COVID-19, although researchers said antiviral treatment alone is probably not sufficient for all patients.